My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
COMPLIANCE INFO_2005-2008
EnvironmentalHealth
>
EHD Program Facility Records by Street Name
>
T
>
TRACY
>
2375
>
2300 - Underground Storage Tank Program
>
PR0231897
>
COMPLIANCE INFO_2005-2008
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
2/15/2024 1:53:27 PM
Creation date
6/3/2020 9:54:36 AM
Metadata
Fields
Template:
EHD - Public
ProgramCode
2300 - Underground Storage Tank Program
File Section
COMPLIANCE INFO
FileName_PostFix
2005-2008
RECORD_ID
PR0231897
PE
2361
FACILITY_ID
FA0006443
FACILITY_NAME
Tracy Texaco
STREET_NUMBER
2375
Direction
N
STREET_NAME
TRACY
STREET_TYPE
BLVD
City
TRACY
Zip
95376
APN
23207003
CURRENT_STATUS
01
SITE_LOCATION
2375 N TRACY BLVD
P_LOCATION
03
P_DISTRICT
005
QC Status
Approved
Scanner
SJGOV\rtan
Supplemental fields
FilePath
\MIGRATIONS\UST\UST_2361_PR0231897_2375 N TRACY_2005-2008.tif
Tags
EHD - Public
Jump to thumbnail
< previous set
next set >
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
381
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
EAT11 & SAFETY 2005 <br /> will collect attendees' signatures indicating their receipt and understanding of the HASP and <br /> their agreement to comply. <br /> 5.4 FIRST-AID AND CPR TRAINING <br /> It is required that the SSHO and at least one other member of the field personnel have First- <br /> Aid and CPR training. This training must be consistent with the requirements of the American <br /> Red Cross Association. Tait's SSHO and at least one other member of the field crew on <br /> site have been trained in First Aid and CPR. <br /> 6.0 HAZARD EVALUATION <br /> Hazards generally encountered during tasks of subsurface investigations and site assessments in the <br /> area of underground storage tanks, consists of; exposure to chemical compounds of hydrocarbons, <br /> halogenated hydrocarbons, and solvents; and the endangerment from operations of heavy <br /> equipment, falls, splashes and spills of fluids, utility lines, and heat stress. <br /> 6.1 HYDROCARBONS <br /> The following briefly summarizes the contaminant group of, and evidence of an individual's <br /> exposure to, hydrocarbons. Other contaminants may be identified during the site <br /> characterization. Various hydrocarbons are usual contaminants associated with underground <br /> storage tanks. In general, hydrocarbons and halogenated hydrocarbon exposures will typically <br /> result in signs of central nervous system disturbances. While the degree of disturbance varies <br /> with each compound, common symptoms of exposure are disorientation, euphoria, giddiness, <br /> and confusion. Most hydrocarbons are also very lipid soluble, which enables them to <br /> penetrate the skin easily, which can result in potential dermatitis conditions. <br /> Benzene is a colorless liquid with an aromatic odor and is considered a human carcinogen. <br /> Exposure to benzene can result in the irritation of the eyes, nose, and respiratory system. <br /> Prolonged exposure can result in giddiness, headache, and lassitude. Dermal exposure can <br /> result in a dermatitis condition. <br /> Benzene is used in this HASP as a chemical of concern because of its known toxicity. <br /> Protecting a worker against benzene exposure should be considered conservative. <br /> Benzene is a known cancer-causing agent (carcinogen), avoid inhalation of vapors. Workers <br /> are required to wear appropriate respiratory protection for exposures to benzene in excess of <br /> the OSHA Permissible Exposure Limit (PEL) of 1 PPM. <br /> Toluene is a component of gasoline, which may pose a health risk to workers performing tank <br /> cleaning and removal operations. Health hazards associated with toluene exposure include; <br /> irritation of the eyes and nose, fatigue, weakness, confusion, dizziness, headache, dilated <br /> pupils, lacrimation, muscle fatigue, insomnia, paresthesia, and dermatitis. Long-term (chronic) <br /> 8 <br />
The URL can be used to link to this page
Your browser does not support the video tag.